NCT05019508 is a clinical trial in Gestational Diabetes, sponsored by University of Virginia.

Who is sponsoring NCT05019508?

NCT05019508 is sponsored by University of Virginia.

What condition does NCT05019508 study?

NCT05019508 studies Gestational Diabetes.

Is NCT05019508 still recruiting?

NCT05019508 is currently completed. Last updated 16 January 2025.

Last reviewed 2025-01-16 · How we verify

NCT05019508

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fetal Cardiac Function Parameters and HbA1c As Screening for Gestational Diabetes Mellitus

Completed Last updated 16 January 2025

What this trial tests

trial in Gestational Diabetes in 114 participants. Completed in 10 April 2023.

Timeline

13 August 2021

Primary endpoint
18 August 2022

10 April 2023

Quick facts

Lead sponsor	University of Virginia
Status	Completed
Study type	OBSERVATIONAL
Enrollment	114
Start date	13 August 2021
Primary completion	18 August 2022
Estimated completion	10 April 2023
Sites	1 location across United States

Conditions studied

Gestational Diabetes — all drugs for Gestational Diabetes →

Sponsor

University of Virginia

Who can join

Adults 18 to 50, female only, with Gestational Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective cohort study to assess the predictive value of fetal cardiac parameters, the change in fetal cardiac parameters (CFP), HbA1c, and/or the change in HbA1c (ΔHbA1c) for gestational diabetes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Gestational Diabetes

Currently open trials in the same condition.

NCT07171684 — Single vs Multi-Dose Insulin for Glycemic Control (SUGAR) · NA · recruiting
NCT07314944 — Maternal Sleep and Lifestyle, Metabolic Health, and Perinatal Outcomes in Gestational Diabetes · recruiting
NCT06571487 — Growth Hormone Resistance of Beta-cells · recruiting
NCT07336914 — Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes · NA · recruiting
NCT07174245 — Pregnancy and Postpartum CGM in GDM · recruiting

Other University of Virginia trials

Trials by the same sponsor.

NCT05880355 — Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI · EARLY_PHASE1 · not yet recruiting
NCT07405645 — Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy · NA · recruiting
NCT07146685 — Effect of Local Anesthetic Concentration on Rebound Pain: A Randomized Control Study · Phase 4 · not yet recruiting
NCT07298941 — Resilience Enhancement Following Sleep Treatment · Phase 2 · recruiting
NCT07036315 — Meaning in Music-Based Pain Modulation · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05019508 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Virginia
Last refreshed: 16 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05019508.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing